Biotech

All Articles

ArsenalBio elevates $325M, pivots off of previous lead possession

.Arsenal Biosciences is actually moving on up. The cell treatment provider has added on $325 million...

Lilly- supported weight loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' cannabis make use of drug flunks stage 2b, steering Indivior to reconsider $100M option

.Aelis Farma's chances of safeguarding a simple, favorable decision on a $one hundred thousand alter...

ProKidney stops phase 3 test not required for cell treatment authorization

.ProKidney has stopped one of a pair of phase 3 trials for its own cell treatment for kidney health ...

Vaxcyte surges on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what professionals called "sensational" phase 1/2 information for its own 31-valen...

Recursion's human brain ailment test presents insufficient documentation of efficiency

.Recursion has stumbled by means of an early examination of its own tech-enabled technique to medica...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Contact it a case of really good chemical make up: Acepodia, a biotech based on Nobel Champion scie...

Praxis epilepsy medicine reduces confiscations in stage 2 litigation

.Praxis Accuracy Medicines has scored one more midphase gain in epilepsy this year, with its salt st...

Three directors surrender as Dyne messages mixed data for DMD candidate

.After escaping a medical grip several years back, Dyne Rehab has actually shown new phase 1/2 data ...

Arrowhead fires off period 3 information in uncommon metabolic disease ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand in advance of a potential face-off with Io...